Literature DB >> 31560980

Clinical features of dermatofibrosarcoma protuberans and risk factors for local recurrence after Mohs micrographic surgery.

Yanan Li1, Chuan Wang1, Kaiying Yang1, Suhua Peng1, Qi Wang1, Siyuan Chen2, Yi Ji3.   

Abstract

Year:  2019        PMID： 31560980     DOI： 10.1016/j.jaad.2019.09.034

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

2.  Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans.

Authors:  Xiao Zhang; Di Sun; Haiyan Zheng; Yamin Rao; Yuqi Deng; Xiao Liang; Jun Chen; Jun Yang
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

3.  Unmasking dermatofibrosarcoma protuberans: Case report of an atypical presentation complicated by post-surgical excision.

Authors:  YaQun Zhou Arlene; Justin Chin; Millard D Strutin; Christine M Lomiguen
Journal:  Int J Surg Case Rep       Date:  2020-04-03

4.  Dermatofibrosarcoma protuberans in a young patient with epidermolysis bullosa: a case report.

Authors:  B Bonaventura; D Kraus; G B Stark; H Fuellgraf; J Kiefer
Journal:  BMC Surg       Date:  2021-02-23       Impact factor: 2.102

5.  Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.

Authors:  Jessica Beaziz; Maxime Battistella; Julie Delyon; Cécile Farges; Oren Marco; Cécile Pages; Christine Le Maignan; Laetitia Da Meda; Nicole Basset-Seguin; Matthieu Resche-Rigon; Anouk Walter Petrich; Delphine Kérob; Céleste Lebbé; Barouyr Baroudjian
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.